Synopsis
So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world s second-most populous country reels from a devastating second wave of infections that killed around 170,000 people in April and May alone.
Reuters
India signed its first order for an unapproved COVID-19 vaccine on Thursday, a day after it faced criticism from the Supreme Court over its bungled vaccine rollout that has left millions of people vulnerable after almost 338,000 deaths.
So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world s second-most populous country reels from a devastating second wave of infections that killed around 170,000 people in April and May alone.
NEW DELHI: India signed its first order for an unapproved COVID-19 vaccine on Thursday, a day after criticism from the Supreme Court over its bungled vaccine rollout that has left millions of people vulnerable after almost 338,000 deaths.
So far, only 4.7 percent of the 950 million adult population have been given two vaccine doses. The world’s second most populous country is reeling from a widespread second wave of infections that killed around 170,000 people in April and May alone.
The government will buy 300 million vaccine doses from local firm Biological-E and has put down an advance of $205.6 million, the health ministry said, even though the vaccine is still going through Phase III clinical trials.
So far, only about 4.7% of the 950 million adult population have been given two vaccine doses as the world s second-most populous country reels from a devastating second wave of infections